nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—SLC16A1—Methotrexate—germ cell cancer	0.223	0.469	CbGbCtD
Niacin—SLC22A5—Dactinomycin—germ cell cancer	0.219	0.462	CbGbCtD
Niacin—CYP2D6—Vinblastine—germ cell cancer	0.0329	0.0692	CbGbCtD
Niacin—NNMT—optic choroid—germ cell cancer	0.0183	0.098	CbGeAlD
Niacin—NNMT—Metapathway biotransformation—NAT9—germ cell cancer	0.0133	0.101	CbGpPWpGaD
Niacin—SLC16A3—optic choroid—germ cell cancer	0.0125	0.0669	CbGeAlD
Niacin—SLC22A5—Organic cation transport—SLC22A3—germ cell cancer	0.00952	0.0726	CbGpPWpGaD
Niacin—SLC16A3—Pyruvate metabolism—CRABP1—germ cell cancer	0.00694	0.0529	CbGpPWpGaD
Niacin—QPRT—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.00679	0.0518	CbGpPWpGaD
Niacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00645	0.0492	CbGpPWpGaD
Niacin—HCAR2—skin of body—germ cell cancer	0.00569	0.0305	CbGeAlD
Niacin—HCAR3—endocrine gland—germ cell cancer	0.00567	0.0304	CbGeAlD
Niacin—SLCO2B1—Transport of organic anions—AVP—germ cell cancer	0.00452	0.0345	CbGpPWpGaD
Niacin—QPRT—endocrine gland—germ cell cancer	0.00449	0.0241	CbGeAlD
Niacin—QPRT—head—germ cell cancer	0.00443	0.0238	CbGeAlD
Niacin—NNMT—trigeminal ganglion—germ cell cancer	0.00427	0.0229	CbGeAlD
Niacin—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.0042	0.032	CbGpPWpGaD
Niacin—SLC5A8—NRF2 pathway—SLC2A3—germ cell cancer	0.00417	0.0318	CbGpPWpGaD
Niacin—HCAR2—endocrine gland—germ cell cancer	0.00376	0.0202	CbGeAlD
Niacin—SLC16A1—Pyruvate metabolism—CRABP1—germ cell cancer	0.00375	0.0286	CbGpPWpGaD
Niacin—NNMT—eye—germ cell cancer	0.00368	0.0197	CbGeAlD
Niacin—HCAR2—testis—germ cell cancer	0.00358	0.0192	CbGeAlD
Niacin—QPRT—brain—germ cell cancer	0.00321	0.0172	CbGeAlD
Niacin—NNMT—decidua—germ cell cancer	0.00318	0.017	CbGeAlD
Niacin—SLCO2B1—ganglion—germ cell cancer	0.0031	0.0166	CbGeAlD
Niacin—SLC16A3—trigeminal ganglion—germ cell cancer	0.00292	0.0156	CbGeAlD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00283	0.0216	CbGpPWpGaD
Niacin—SLC16A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00278	0.0212	CbGpPWpGaD
Niacin—NNMT—uterus—germ cell cancer	0.00278	0.0149	CbGeAlD
Niacin—NNMT—pituitary gland—germ cell cancer	0.00273	0.0146	CbGeAlD
Niacin—NNMT—medulla oblongata—germ cell cancer	0.00263	0.0141	CbGeAlD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00263	0.0201	CbGpPWpGaD
Niacin—HCAR2—lymph node—germ cell cancer	0.0026	0.0139	CbGeAlD
Niacin—SLC5A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00259	0.0198	CbGpPWpGaD
Niacin—SLC16A3—brainstem—germ cell cancer	0.00258	0.0138	CbGeAlD
Niacin—SLC16A3—eye—germ cell cancer	0.00251	0.0135	CbGeAlD
Niacin—SLC16A3—retina—germ cell cancer	0.00249	0.0134	CbGeAlD
Niacin—NNMT—adrenal gland—germ cell cancer	0.00244	0.0131	CbGeAlD
Niacin—NNMT—midbrain—germ cell cancer	0.00241	0.0129	CbGeAlD
Niacin—NNMT—bone marrow—germ cell cancer	0.00236	0.0127	CbGeAlD
Niacin—NNMT—spinal cord—germ cell cancer	0.00235	0.0126	CbGeAlD
Niacin—SLC16A3—telencephalon—germ cell cancer	0.00229	0.0123	CbGeAlD
Niacin—NNMT—female gonad—germ cell cancer	0.00227	0.0122	CbGeAlD
Niacin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—CRABP1—germ cell cancer	0.00227	0.0173	CbGpPWpGaD
Niacin—SLC16A3—decidua—germ cell cancer	0.00217	0.0116	CbGeAlD
Niacin—NNMT—endocrine gland—germ cell cancer	0.00211	0.0113	CbGeAlD
Niacin—NNMT—head—germ cell cancer	0.00209	0.0112	CbGeAlD
Niacin—SLC5A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00204	0.0156	CbGpPWpGaD
Niacin—NNMT—testis—germ cell cancer	0.00202	0.0108	CbGeAlD
Niacin—CYP2D6—urine—germ cell cancer	0.00195	0.0105	CbGeAlD
Niacin—SLC16A3—gonad—germ cell cancer	0.00191	0.0103	CbGeAlD
Niacin—SLC16A3—uterus—germ cell cancer	0.0019	0.0102	CbGeAlD
Niacin—SLC16A3—pituitary gland—germ cell cancer	0.00186	0.01	CbGeAlD
Niacin—NNMT—cerebellum—germ cell cancer	0.00186	0.00999	CbGeAlD
Niacin—SLC16A3—medulla oblongata—germ cell cancer	0.0018	0.00965	CbGeAlD
Niacin—SLCO2B1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.00168	0.0128	CbGpPWpGaD
Niacin—SLC16A3—adrenal gland—germ cell cancer	0.00167	0.00893	CbGeAlD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.00163	0.0124	CbGpPWpGaD
Niacin—SLC16A3—bone marrow—germ cell cancer	0.00161	0.00864	CbGeAlD
Niacin—SLC16A3—female gonad—germ cell cancer	0.00155	0.00833	CbGeAlD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00153	0.0116	CbGpPWpGaD
Niacin—SLC16A1—eye—germ cell cancer	0.00153	0.00818	CbGeAlD
Niacin—NNMT—brain—germ cell cancer	0.00151	0.00811	CbGeAlD
Niacin—SLC16A1—retina—germ cell cancer	0.00151	0.00811	CbGeAlD
Niacin—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.0015	0.0115	CbGpPWpGaD
Niacin—NNMT—lymph node—germ cell cancer	0.00146	0.00784	CbGeAlD
Niacin—SLC16A3—endocrine gland—germ cell cancer	0.00144	0.00775	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00143	0.0109	CbGpPWpGaD
Niacin—SLC16A3—head—germ cell cancer	0.00143	0.00765	CbGeAlD
Niacin—SLC16A1—telencephalon—germ cell cancer	0.00139	0.00746	CbGeAlD
Niacin—SLC16A3—testis—germ cell cancer	0.00138	0.00739	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00136	0.0104	CbGpPWpGaD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.00134	0.0102	CbGpPWpGaD
Niacin—SLC16A1—decidua—germ cell cancer	0.00132	0.00707	CbGeAlD
Niacin—SLC5A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00132	0.01	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00131	0.01	CbGpPWpGaD
Niacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00129	0.00986	CbGpPWpGaD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00128	0.0098	CbGpPWpGaD
Niacin—SLC16A3—cerebellum—germ cell cancer	0.00127	0.00682	CbGeAlD
Niacin—SLC16A3—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00127	0.00965	CbGpPWpGaD
Niacin—SLC5A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00121	0.00926	CbGpPWpGaD
Niacin—SLCO2B1—telencephalon—germ cell cancer	0.0012	0.00642	CbGeAlD
Niacin—SLC16A1—gonad—germ cell cancer	0.00116	0.00623	CbGeAlD
Niacin—SLC16A1—uterus—germ cell cancer	0.00115	0.00619	CbGeAlD
Niacin—SLCO2B1—decidua—germ cell cancer	0.00113	0.00608	CbGeAlD
Niacin—SLC16A1—pituitary gland—germ cell cancer	0.00113	0.00608	CbGeAlD
Niacin—SLC16A1—medulla oblongata—germ cell cancer	0.00109	0.00586	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—OXT—germ cell cancer	0.00109	0.00833	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—OXT—germ cell cancer	0.00104	0.0079	CbGpPWpGaD
Niacin—SLC16A3—brain—germ cell cancer	0.00103	0.00554	CbGeAlD
Niacin—SLC22A5—trigeminal ganglion—germ cell cancer	0.00101	0.00543	CbGeAlD
Niacin—SLC16A1—adrenal gland—germ cell cancer	0.00101	0.00543	CbGeAlD
Niacin—SLC16A1—midbrain—germ cell cancer	0.000999	0.00536	CbGeAlD
Niacin—SLC16A3—lymph node—germ cell cancer	0.000998	0.00536	CbGeAlD
Niacin—SLC16A3—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000998	0.00761	CbGpPWpGaD
Niacin—SLCO2B1—uterus—germ cell cancer	0.000992	0.00532	CbGeAlD
Niacin—HCAR2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000983	0.0075	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000976	0.00745	CbGpPWpGaD
Niacin—SLC16A1—spinal cord—germ cell cancer	0.000975	0.00523	CbGeAlD
Niacin—SLC16A1—female gonad—germ cell cancer	0.000943	0.00506	CbGeAlD
Niacin—SLCO2B1—medulla oblongata—germ cell cancer	0.00094	0.00504	CbGeAlD
Niacin—HCAR3—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000932	0.00711	CbGpPWpGaD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.000879	0.00671	CbGpPWpGaD
Niacin—SLC16A1—endocrine gland—germ cell cancer	0.000877	0.00471	CbGeAlD
Niacin—SLCO2B1—adrenal gland—germ cell cancer	0.00087	0.00467	CbGeAlD
Niacin—SLC16A1—head—germ cell cancer	0.000866	0.00465	CbGeAlD
Niacin—SLC22A5—retina—germ cell cancer	0.000864	0.00463	CbGeAlD
Niacin—SLCO2B1—spinal cord—germ cell cancer	0.000838	0.0045	CbGeAlD
Niacin—SLC16A1—testis—germ cell cancer	0.000837	0.00449	CbGeAlD
Niacin—SLCO2B1—female gonad—germ cell cancer	0.000812	0.00435	CbGeAlD
Niacin—QPRT—Disease—SLC2A3—germ cell cancer	0.000804	0.00613	CbGpPWpGaD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000781	0.00596	CbGpPWpGaD
Niacin—Hypoaesthesia—Bleomycin—germ cell cancer	0.000773	0.00373	CcSEcCtD
Niacin—SLC16A1—cerebellum—germ cell cancer	0.000773	0.00415	CbGeAlD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000769	0.00587	CbGpPWpGaD
Niacin—SLC22A5—skin of body—germ cell cancer	0.000758	0.00407	CbGeAlD
Niacin—Orthostatic hypotension—Cisplatin—germ cell cancer	0.000756	0.00365	CcSEcCtD
Niacin—SLCO2B1—endocrine gland—germ cell cancer	0.000755	0.00405	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—AVP—germ cell cancer	0.000749	0.00571	CbGpPWpGaD
Niacin—SLCO2B1—head—germ cell cancer	0.000745	0.004	CbGeAlD
Niacin—SLC16A3—Hemostasis—CD9—germ cell cancer	0.000732	0.00558	CbGpPWpGaD
Niacin—Hepatitis—Dactinomycin—germ cell cancer	0.000725	0.0035	CcSEcCtD
Niacin—Flushing—Bleomycin—germ cell cancer	0.000721	0.00348	CcSEcCtD
Niacin—Stomatitis—Ifosfamide—germ cell cancer	0.000721	0.00348	CcSEcCtD
Niacin—SLCO2B1—testis—germ cell cancer	0.00072	0.00386	CbGeAlD
Niacin—Vertigo—Vinblastine—germ cell cancer	0.00072	0.00347	CcSEcCtD
Niacin—Leukopenia—Vinblastine—germ cell cancer	0.000717	0.00346	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—AVP—germ cell cancer	0.00071	0.00542	CbGpPWpGaD
Niacin—Chills—Bleomycin—germ cell cancer	0.000697	0.00336	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000694	0.00529	CbGpPWpGaD
Niacin—Skin discolouration—Methotrexate—germ cell cancer	0.000693	0.00334	CcSEcCtD
Niacin—Bone disorder—Methotrexate—germ cell cancer	0.000693	0.00334	CcSEcCtD
Niacin—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.000688	0.00332	CcSEcCtD
Niacin—Alopecia—Bleomycin—germ cell cancer	0.000687	0.00331	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000683	0.00521	CbGpPWpGaD
Niacin—Erythema—Bleomycin—germ cell cancer	0.000676	0.00326	CcSEcCtD
Niacin—Hyperuricaemia—Methotrexate—germ cell cancer	0.000674	0.00325	CcSEcCtD
Niacin—QPRT—Metabolism—SLC2A3—germ cell cancer	0.000673	0.00514	CbGpPWpGaD
Niacin—Flushing—Dactinomycin—germ cell cancer	0.000673	0.00325	CcSEcCtD
Niacin—Haemoglobin—Ifosfamide—germ cell cancer	0.000667	0.00322	CcSEcCtD
Niacin—SLCO2B1—cerebellum—germ cell cancer	0.000665	0.00357	CbGeAlD
Niacin—Haemorrhage—Ifosfamide—germ cell cancer	0.000664	0.0032	CcSEcCtD
Niacin—Hepatitis—Ifosfamide—germ cell cancer	0.000664	0.0032	CcSEcCtD
Niacin—QPRT—Metabolism—SLC22A3—germ cell cancer	0.000663	0.00506	CbGpPWpGaD
Niacin—Dysphagia—Etoposide—germ cell cancer	0.000655	0.00316	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000653	0.00498	CbGpPWpGaD
Niacin—Chills—Dactinomycin—germ cell cancer	0.00065	0.00314	CcSEcCtD
Niacin—SLC22A5—pituitary gland—germ cell cancer	0.000647	0.00347	CbGeAlD
Niacin—SLC16A3—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000643	0.00491	CbGpPWpGaD
Niacin—Alopecia—Dactinomycin—germ cell cancer	0.00064	0.00309	CcSEcCtD
Niacin—Visual impairment—Ifosfamide—germ cell cancer	0.00064	0.00309	CcSEcCtD
Niacin—Blood uric acid increased—Methotrexate—germ cell cancer	0.000637	0.00307	CcSEcCtD
Niacin—Erythema—Dactinomycin—germ cell cancer	0.000631	0.00304	CcSEcCtD
Niacin—SLC16A1—brain—germ cell cancer	0.000628	0.00337	CbGeAlD
Niacin—NNMT—Metabolism—SLC2A3—germ cell cancer	0.000626	0.00478	CbGpPWpGaD
Niacin—Vaginal inflammation—Methotrexate—germ cell cancer	0.000626	0.00302	CcSEcCtD
Niacin—SLC22A5—medulla oblongata—germ cell cancer	0.000624	0.00335	CbGeAlD
Niacin—Anorexia—Vinblastine—germ cell cancer	0.000623	0.00301	CcSEcCtD
Niacin—Stomatitis—Cisplatin—germ cell cancer	0.000622	0.003	CcSEcCtD
Niacin—Eye disorder—Ifosfamide—germ cell cancer	0.000621	0.00299	CcSEcCtD
Niacin—Tinnitus—Ifosfamide—germ cell cancer	0.000619	0.00299	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—OXT—germ cell cancer	0.000617	0.00471	CbGpPWpGaD
Niacin—NNMT—Metabolism—SLC22A3—germ cell cancer	0.000617	0.0047	CbGpPWpGaD
Niacin—Flushing—Ifosfamide—germ cell cancer	0.000616	0.00297	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000616	0.0047	CbGpPWpGaD
Niacin—SLC16A1—lymph node—germ cell cancer	0.000606	0.00325	CbGeAlD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000606	0.00463	CbGpPWpGaD
Niacin—Leukopenia—Bleomycin—germ cell cancer	0.000605	0.00292	CcSEcCtD
Niacin—Angiopathy—Ifosfamide—germ cell cancer	0.000603	0.00291	CcSEcCtD
Niacin—Skin exfoliation—Methotrexate—germ cell cancer	0.000597	0.00288	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000596	0.00455	CbGpPWpGaD
Niacin—Chills—Ifosfamide—germ cell cancer	0.000596	0.00288	CcSEcCtD
Niacin—Arrhythmia—Ifosfamide—germ cell cancer	0.000593	0.00286	CcSEcCtD
Niacin—SLC16A3—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000592	0.00452	CbGpPWpGaD
Niacin—Vaginal infection—Methotrexate—germ cell cancer	0.000591	0.00285	CcSEcCtD
Niacin—Cough—Bleomycin—germ cell cancer	0.00059	0.00285	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000587	0.00448	CbGpPWpGaD
Niacin—Paraesthesia—Vinblastine—germ cell cancer	0.000587	0.00283	CcSEcCtD
Niacin—Alopecia—Ifosfamide—germ cell cancer	0.000587	0.00283	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—OXT—germ cell cancer	0.000585	0.00447	CbGpPWpGaD
Niacin—Erythema—Ifosfamide—germ cell cancer	0.000578	0.00279	CcSEcCtD
Niacin—Malnutrition—Ifosfamide—germ cell cancer	0.000578	0.00279	CcSEcCtD
Niacin—SLC22A5—adrenal gland—germ cell cancer	0.000578	0.0031	CbGeAlD
Niacin—CYP2D6—brainstem—germ cell cancer	0.000578	0.0031	CbGeAlD
Niacin—Myalgia—Bleomycin—germ cell cancer	0.000576	0.00278	CcSEcCtD
Niacin—SLC22A5—midbrain—germ cell cancer	0.000571	0.00306	CbGeAlD
Niacin—Jaundice—Etoposide—germ cell cancer	0.000569	0.00275	CcSEcCtD
Niacin—Stomatitis—Etoposide—germ cell cancer	0.000569	0.00275	CcSEcCtD
Niacin—Decreased appetite—Vinblastine—germ cell cancer	0.000568	0.00274	CcSEcCtD
Niacin—Urine output increased—Methotrexate—germ cell cancer	0.000566	0.00273	CcSEcCtD
Niacin—Leukopenia—Dactinomycin—germ cell cancer	0.000565	0.00273	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—OXT—germ cell cancer	0.000561	0.00428	CbGpPWpGaD
Niacin—Pain—Vinblastine—germ cell cancer	0.000559	0.0027	CcSEcCtD
Niacin—SLC22A5—spinal cord—germ cell cancer	0.000557	0.00299	CbGeAlD
Niacin—Oedema—Bleomycin—germ cell cancer	0.000552	0.00266	CcSEcCtD
Niacin—Anaphylactic shock—Bleomycin—germ cell cancer	0.000552	0.00266	CcSEcCtD
Niacin—Visual impairment—Cisplatin—germ cell cancer	0.000552	0.00266	CcSEcCtD
Niacin—Vision blurred—Ifosfamide—germ cell cancer	0.000545	0.00263	CcSEcCtD
Niacin—QPRT—Metabolism—CRABP1—germ cell cancer	0.000541	0.00413	CbGpPWpGaD
Niacin—SLCO2B1—brain—germ cell cancer	0.00054	0.0029	CbGeAlD
Niacin—SLC22A5—female gonad—germ cell cancer	0.000539	0.00289	CbGeAlD
Niacin—SLC16A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000539	0.00411	CbGpPWpGaD
Niacin—Myalgia—Dactinomycin—germ cell cancer	0.000537	0.00259	CcSEcCtD
Niacin—Eye disorder—Cisplatin—germ cell cancer	0.000535	0.00258	CcSEcCtD
Niacin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000534	0.00258	CcSEcCtD
Niacin—Tinnitus—Cisplatin—germ cell cancer	0.000534	0.00258	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—OXT—germ cell cancer	0.000531	0.00405	CbGpPWpGaD
Niacin—Flushing—Cisplatin—germ cell cancer	0.000531	0.00256	CcSEcCtD
Niacin—Angioedema—Ifosfamide—germ cell cancer	0.000528	0.00255	CcSEcCtD
Niacin—Anorexia—Bleomycin—germ cell cancer	0.000526	0.00254	CcSEcCtD
Niacin—Diabetes mellitus—Methotrexate—germ cell cancer	0.000522	0.00252	CcSEcCtD
Niacin—Hypoaesthesia—Etoposide—germ cell cancer	0.000522	0.00252	CcSEcCtD
Niacin—SLCO2B1—lymph node—germ cell cancer	0.000522	0.0028	CbGeAlD
Niacin—Vertigo—Ifosfamide—germ cell cancer	0.000519	0.00251	CcSEcCtD
Niacin—Leukopenia—Ifosfamide—germ cell cancer	0.000517	0.0025	CcSEcCtD
Niacin—Polyuria—Methotrexate—germ cell cancer	0.000517	0.0025	CcSEcCtD
Niacin—Abdominal pain—Vinblastine—germ cell cancer	0.000517	0.00249	CcSEcCtD
Niacin—Hypotension—Bleomycin—germ cell cancer	0.000516	0.00249	CcSEcCtD
Niacin—Oedema—Dactinomycin—germ cell cancer	0.000515	0.00248	CcSEcCtD
Niacin—CYP2D6—telencephalon—germ cell cancer	0.000513	0.00275	CbGeAlD
Niacin—Arrhythmia—Cisplatin—germ cell cancer	0.000511	0.00247	CcSEcCtD
Niacin—Palpitations—Ifosfamide—germ cell cancer	0.000511	0.00247	CcSEcCtD
Niacin—Alopecia—Cisplatin—germ cell cancer	0.000506	0.00244	CcSEcCtD
Niacin—Cough—Ifosfamide—germ cell cancer	0.000504	0.00243	CcSEcCtD
Niacin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000503	0.00243	CcSEcCtD
Niacin—NNMT—Metabolism—CRABP1—germ cell cancer	0.000503	0.00384	CbGpPWpGaD
Niacin—Erythema—Cisplatin—germ cell cancer	0.000498	0.00241	CcSEcCtD
Niacin—Malnutrition—Cisplatin—germ cell cancer	0.000498	0.00241	CcSEcCtD
Niacin—Paraesthesia—Bleomycin—germ cell cancer	0.000496	0.00239	CcSEcCtD
Niacin—Dyspnoea—Bleomycin—germ cell cancer	0.000492	0.00238	CcSEcCtD
Niacin—Myalgia—Ifosfamide—germ cell cancer	0.000492	0.00238	CcSEcCtD
Niacin—Arthralgia—Ifosfamide—germ cell cancer	0.000492	0.00238	CcSEcCtD
Niacin—Flatulence—Cisplatin—germ cell cancer	0.000491	0.00237	CcSEcCtD
Niacin—Anorexia—Dactinomycin—germ cell cancer	0.000491	0.00237	CcSEcCtD
Niacin—Eye disorder—Etoposide—germ cell cancer	0.00049	0.00237	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000489	0.00236	CcSEcCtD
Niacin—Flushing—Etoposide—germ cell cancer	0.000487	0.00235	CcSEcCtD
Niacin—Hypersensitivity—Vinblastine—germ cell cancer	0.000482	0.00232	CcSEcCtD
Niacin—Decreased appetite—Bleomycin—germ cell cancer	0.00048	0.00232	CcSEcCtD
Niacin—Muscle spasms—Cisplatin—germ cell cancer	0.000479	0.00231	CcSEcCtD
Niacin—SLC22A5—testis—germ cell cancer	0.000478	0.00256	CbGeAlD
Niacin—Angiopathy—Etoposide—germ cell cancer	0.000476	0.0023	CcSEcCtD
Niacin—Pain—Bleomycin—germ cell cancer	0.000472	0.00228	CcSEcCtD
Niacin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000472	0.00228	CcSEcCtD
Niacin—Oedema—Ifosfamide—germ cell cancer	0.000472	0.00228	CcSEcCtD
Niacin—Chills—Etoposide—germ cell cancer	0.000471	0.00227	CcSEcCtD
Niacin—Vision blurred—Cisplatin—germ cell cancer	0.00047	0.00227	CcSEcCtD
Niacin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000469	0.00226	CcSEcCtD
Niacin—Asthenia—Vinblastine—germ cell cancer	0.000469	0.00226	CcSEcCtD
Niacin—Alopecia—Etoposide—germ cell cancer	0.000463	0.00224	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000463	0.00353	CbGpPWpGaD
Niacin—QPRT—Disease—FGF4—germ cell cancer	0.000462	0.00352	CbGpPWpGaD
Niacin—Skin disorder—Ifosfamide—germ cell cancer	0.000458	0.00221	CcSEcCtD
Niacin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000456	0.0022	CcSEcCtD
Niacin—Anorexia—Ifosfamide—germ cell cancer	0.00045	0.00217	CcSEcCtD
Niacin—Decreased appetite—Dactinomycin—germ cell cancer	0.000448	0.00216	CcSEcCtD
Niacin—Diarrhoea—Vinblastine—germ cell cancer	0.000447	0.00216	CcSEcCtD
Niacin—Leukopenia—Cisplatin—germ cell cancer	0.000446	0.00215	CcSEcCtD
Niacin—SLC22A5—cerebellum—germ cell cancer	0.000441	0.00237	CbGeAlD
Niacin—Hypotension—Ifosfamide—germ cell cancer	0.000441	0.00213	CcSEcCtD
Niacin—Pain—Dactinomycin—germ cell cancer	0.00044	0.00212	CcSEcCtD
Niacin—Muscle spasms—Etoposide—germ cell cancer	0.000439	0.00212	CcSEcCtD
Niacin—Urticaria—Bleomycin—germ cell cancer	0.000439	0.00212	CcSEcCtD
Niacin—Body temperature increased—Bleomycin—germ cell cancer	0.000436	0.00211	CcSEcCtD
Niacin—Dizziness—Vinblastine—germ cell cancer	0.000432	0.00209	CcSEcCtD
Niacin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00043	0.00207	CcSEcCtD
Niacin—Myalgia—Cisplatin—germ cell cancer	0.000424	0.00205	CcSEcCtD
Niacin—Paraesthesia—Ifosfamide—germ cell cancer	0.000424	0.00204	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—AVP—germ cell cancer	0.000423	0.00323	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000421	0.00203	CcSEcCtD
Niacin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000421	0.00203	CcSEcCtD
Niacin—Dyspnoea—Ifosfamide—germ cell cancer	0.000421	0.00203	CcSEcCtD
Niacin—Somnolence—Ifosfamide—germ cell cancer	0.000419	0.00202	CcSEcCtD
Niacin—Liver function test abnormal—Methotrexate—germ cell cancer	0.000419	0.00202	CcSEcCtD
Niacin—Vomiting—Vinblastine—germ cell cancer	0.000416	0.00201	CcSEcCtD
Niacin—QPRT—Disease—H2AFZ—germ cell cancer	0.000412	0.00315	CbGpPWpGaD
Niacin—Vertigo—Etoposide—germ cell cancer	0.00041	0.00198	CcSEcCtD
Niacin—Decreased appetite—Ifosfamide—germ cell cancer	0.00041	0.00198	CcSEcCtD
Niacin—Headache—Vinblastine—germ cell cancer	0.000409	0.00198	CcSEcCtD
Niacin—Leukopenia—Etoposide—germ cell cancer	0.000409	0.00197	CcSEcCtD
Niacin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000407	0.00197	CcSEcCtD
Niacin—Abdominal pain—Dactinomycin—germ cell cancer	0.000407	0.00196	CcSEcCtD
Niacin—Body temperature increased—Dactinomycin—germ cell cancer	0.000407	0.00196	CcSEcCtD
Niacin—Oedema—Cisplatin—germ cell cancer	0.000407	0.00196	CcSEcCtD
Niacin—Anaphylactic shock—Cisplatin—germ cell cancer	0.000407	0.00196	CcSEcCtD
Niacin—Hypersensitivity—Bleomycin—germ cell cancer	0.000407	0.00196	CcSEcCtD
Niacin—Pain—Ifosfamide—germ cell cancer	0.000403	0.00195	CcSEcCtD
Niacin—Loss of consciousness—Etoposide—germ cell cancer	0.000401	0.00194	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—AVP—germ cell cancer	0.000401	0.00306	CbGpPWpGaD
Niacin—Cough—Etoposide—germ cell cancer	0.000398	0.00192	CcSEcCtD
Niacin—Tachycardia—Cisplatin—germ cell cancer	0.000397	0.00192	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000397	0.00303	CbGpPWpGaD
Niacin—Asthenia—Bleomycin—germ cell cancer	0.000396	0.00191	CcSEcCtD
Niacin—SLC16A1—Hemostasis—CD9—germ cell cancer	0.000395	0.00302	CbGpPWpGaD
Niacin—Skin disorder—Cisplatin—germ cell cancer	0.000395	0.00191	CcSEcCtD
Niacin—Hyperhidrosis—Cisplatin—germ cell cancer	0.000393	0.0019	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000391	0.00298	CbGpPWpGaD
Niacin—Pruritus—Bleomycin—germ cell cancer	0.000391	0.00188	CcSEcCtD
Niacin—Nausea—Vinblastine—germ cell cancer	0.000388	0.00187	CcSEcCtD
Niacin—Anorexia—Cisplatin—germ cell cancer	0.000388	0.00187	CcSEcCtD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	0.000387	0.00295	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000386	0.00186	CcSEcCtD
Niacin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000386	0.00186	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—AVP—germ cell cancer	0.000384	0.00293	CbGpPWpGaD
Niacin—Hypotension—Cisplatin—germ cell cancer	0.00038	0.00183	CcSEcCtD
Niacin—QPRT—Disease—KITLG—germ cell cancer	0.000379	0.00289	CbGpPWpGaD
Niacin—Hypersensitivity—Dactinomycin—germ cell cancer	0.000379	0.00183	CcSEcCtD
Niacin—Urticaria—Ifosfamide—germ cell cancer	0.000375	0.00181	CcSEcCtD
Niacin—Abdominal pain—Ifosfamide—germ cell cancer	0.000373	0.0018	CcSEcCtD
Niacin—Body temperature increased—Ifosfamide—germ cell cancer	0.000373	0.0018	CcSEcCtD
Niacin—Anaphylactic shock—Etoposide—germ cell cancer	0.000373	0.0018	CcSEcCtD
Niacin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000371	0.00179	CcSEcCtD
Niacin—Asthenia—Dactinomycin—germ cell cancer	0.000369	0.00178	CcSEcCtD
Niacin—Paraesthesia—Cisplatin—germ cell cancer	0.000365	0.00176	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—AVP—germ cell cancer	0.000364	0.00278	CbGpPWpGaD
Niacin—Tachycardia—Etoposide—germ cell cancer	0.000364	0.00176	CcSEcCtD
Niacin—Dyspnoea—Cisplatin—germ cell cancer	0.000363	0.00175	CcSEcCtD
Niacin—Skin disorder—Etoposide—germ cell cancer	0.000362	0.00175	CcSEcCtD
Niacin—Erectile dysfunction—Methotrexate—germ cell cancer	0.000361	0.00174	CcSEcCtD
Niacin—Hyperhidrosis—Etoposide—germ cell cancer	0.00036	0.00174	CcSEcCtD
Niacin—SLCO2B1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00036	0.00275	CbGpPWpGaD
Niacin—SLC22A5—brain—germ cell cancer	0.000359	0.00192	CbGeAlD
Niacin—Anorexia—Etoposide—germ cell cancer	0.000355	0.00171	CcSEcCtD
Niacin—Decreased appetite—Cisplatin—germ cell cancer	0.000354	0.00171	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000352	0.00269	CbGpPWpGaD
Niacin—Diarrhoea—Dactinomycin—germ cell cancer	0.000352	0.0017	CcSEcCtD
Niacin—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000351	0.00169	CcSEcCtD
Niacin—Vomiting—Bleomycin—germ cell cancer	0.000351	0.00169	CcSEcCtD
Niacin—Hypotension—Etoposide—germ cell cancer	0.000348	0.00168	CcSEcCtD
Niacin—Rash—Bleomycin—germ cell cancer	0.000348	0.00168	CcSEcCtD
Niacin—Pain—Cisplatin—germ cell cancer	0.000348	0.00168	CcSEcCtD
Niacin—CYP2D6—female gonad—germ cell cancer	0.000348	0.00187	CbGeAlD
Niacin—Dermatitis—Bleomycin—germ cell cancer	0.000348	0.00168	CcSEcCtD
Niacin—Hypersensitivity—Ifosfamide—germ cell cancer	0.000348	0.00168	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000347	0.00265	CbGpPWpGaD
Niacin—SLC22A5—lymph node—germ cell cancer	0.000347	0.00186	CbGeAlD
Niacin—Stomatitis—Methotrexate—germ cell cancer	0.000341	0.00165	CcSEcCtD
Niacin—Asthenia—Ifosfamide—germ cell cancer	0.000339	0.00163	CcSEcCtD
Niacin—Sweating—Methotrexate—germ cell cancer	0.000336	0.00162	CcSEcCtD
Niacin—Paraesthesia—Etoposide—germ cell cancer	0.000335	0.00161	CcSEcCtD
Niacin—Pruritus—Ifosfamide—germ cell cancer	0.000334	0.00161	CcSEcCtD
Niacin—Dyspnoea—Etoposide—germ cell cancer	0.000332	0.0016	CcSEcCtD
Niacin—Somnolence—Etoposide—germ cell cancer	0.000331	0.0016	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—OXT—germ cell cancer	0.000331	0.00253	CbGpPWpGaD
Niacin—Nausea—Bleomycin—germ cell cancer	0.000328	0.00158	CcSEcCtD
Niacin—Vomiting—Dactinomycin—germ cell cancer	0.000327	0.00158	CcSEcCtD
Niacin—Rash—Dactinomycin—germ cell cancer	0.000325	0.00157	CcSEcCtD
Niacin—Decreased appetite—Etoposide—germ cell cancer	0.000324	0.00156	CcSEcCtD
Niacin—CYP2D6—endocrine gland—germ cell cancer	0.000323	0.00174	CbGeAlD
Niacin—Diarrhoea—Ifosfamide—germ cell cancer	0.000323	0.00156	CcSEcCtD
Niacin—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000322	0.00155	CcSEcCtD
Niacin—Body temperature increased—Cisplatin—germ cell cancer	0.000322	0.00155	CcSEcCtD
Niacin—SLC16A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.00032	0.00244	CbGpPWpGaD
Niacin—CYP2D6—head—germ cell cancer	0.000319	0.00171	CbGeAlD
Niacin—Pain—Etoposide—germ cell cancer	0.000319	0.00154	CcSEcCtD
Niacin—Haemoglobin—Methotrexate—germ cell cancer	0.000316	0.00152	CcSEcCtD
Niacin—Haemorrhage—Methotrexate—germ cell cancer	0.000314	0.00152	CcSEcCtD
Niacin—Hepatitis—Methotrexate—germ cell cancer	0.000314	0.00152	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—OXT—germ cell cancer	0.000314	0.0024	CbGpPWpGaD
Niacin—Dizziness—Ifosfamide—germ cell cancer	0.000312	0.00151	CcSEcCtD
Niacin—CYP2D6—testis—germ cell cancer	0.000308	0.00165	CbGeAlD
Niacin—Nausea—Dactinomycin—germ cell cancer	0.000306	0.00148	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC2A3—germ cell cancer	0.000306	0.00233	CbGpPWpGaD
Niacin—Gastrointestinal pain—Etoposide—germ cell cancer	0.000305	0.00147	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000303	0.00231	CbGpPWpGaD
Niacin—Visual impairment—Methotrexate—germ cell cancer	0.000303	0.00146	CcSEcCtD
Niacin—SLC16A3—Metabolism—SLC22A3—germ cell cancer	0.000301	0.0023	CbGpPWpGaD
Niacin—SLC16A3—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000301	0.0023	CbGpPWpGaD
Niacin—Vomiting—Ifosfamide—germ cell cancer	0.0003	0.00145	CcSEcCtD
Niacin—Hypersensitivity—Cisplatin—germ cell cancer	0.0003	0.00145	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000299	0.00228	CbGpPWpGaD
Niacin—Rash—Ifosfamide—germ cell cancer	0.000297	0.00144	CcSEcCtD
Niacin—Dermatitis—Ifosfamide—germ cell cancer	0.000297	0.00143	CcSEcCtD
Niacin—Urticaria—Etoposide—germ cell cancer	0.000296	0.00143	CcSEcCtD
Niacin—Body temperature increased—Etoposide—germ cell cancer	0.000295	0.00142	CcSEcCtD
Niacin—Abdominal pain—Etoposide—germ cell cancer	0.000295	0.00142	CcSEcCtD
Niacin—Eye disorder—Methotrexate—germ cell cancer	0.000294	0.00142	CcSEcCtD
Niacin—Tinnitus—Methotrexate—germ cell cancer	0.000293	0.00141	CcSEcCtD
Niacin—Asthenia—Cisplatin—germ cell cancer	0.000292	0.00141	CcSEcCtD
Niacin—Angiopathy—Methotrexate—germ cell cancer	0.000285	0.00138	CcSEcCtD
Niacin—CYP2D6—cerebellum—germ cell cancer	0.000285	0.00153	CbGeAlD
Niacin—HCAR2—Signaling Pathways—FGF4—germ cell cancer	0.000283	0.00216	CbGpPWpGaD
Niacin—QPRT—Disease—FGFR3—germ cell cancer	0.000282	0.00215	CbGpPWpGaD
Niacin—Chills—Methotrexate—germ cell cancer	0.000282	0.00136	CcSEcCtD
Niacin—Nausea—Ifosfamide—germ cell cancer	0.00028	0.00135	CcSEcCtD
Niacin—Diarrhoea—Cisplatin—germ cell cancer	0.000278	0.00134	CcSEcCtD
Niacin—Alopecia—Methotrexate—germ cell cancer	0.000278	0.00134	CcSEcCtD
Niacin—SLC22A5—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000275	0.0021	CbGpPWpGaD
Niacin—Hypersensitivity—Etoposide—germ cell cancer	0.000275	0.00132	CcSEcCtD
Niacin—Malnutrition—Methotrexate—germ cell cancer	0.000273	0.00132	CcSEcCtD
Niacin—Erythema—Methotrexate—germ cell cancer	0.000273	0.00132	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—FGF4—germ cell cancer	0.000268	0.00204	CbGpPWpGaD
Niacin—Asthenia—Etoposide—germ cell cancer	0.000267	0.00129	CcSEcCtD
Niacin—Pruritus—Etoposide—germ cell cancer	0.000264	0.00127	CcSEcCtD
Niacin—QPRT—Disease—KIT—germ cell cancer	0.000259	0.00198	CbGpPWpGaD
Niacin—Vomiting—Cisplatin—germ cell cancer	0.000259	0.00125	CcSEcCtD
Niacin—Vision blurred—Methotrexate—germ cell cancer	0.000258	0.00124	CcSEcCtD
Niacin—Rash—Cisplatin—germ cell cancer	0.000256	0.00124	CcSEcCtD
Niacin—Dermatitis—Cisplatin—germ cell cancer	0.000256	0.00124	CcSEcCtD
Niacin—Diarrhoea—Etoposide—germ cell cancer	0.000255	0.00123	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—H2AFZ—germ cell cancer	0.000252	0.00193	CbGpPWpGaD
Niacin—Dizziness—Etoposide—germ cell cancer	0.000246	0.00119	CcSEcCtD
Niacin—Vertigo—Methotrexate—germ cell cancer	0.000246	0.00119	CcSEcCtD
Niacin—SLC16A3—Metabolism—CRABP1—germ cell cancer	0.000245	0.00187	CbGpPWpGaD
Niacin—Leukopenia—Methotrexate—germ cell cancer	0.000245	0.00118	CcSEcCtD
Niacin—Nausea—Cisplatin—germ cell cancer	0.000242	0.00117	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—H2AFZ—germ cell cancer	0.000239	0.00183	CbGpPWpGaD
Niacin—Cough—Methotrexate—germ cell cancer	0.000239	0.00115	CcSEcCtD
Niacin—Vomiting—Etoposide—germ cell cancer	0.000237	0.00114	CcSEcCtD
Niacin—Rash—Etoposide—germ cell cancer	0.000235	0.00113	CcSEcCtD
Niacin—Dermatitis—Etoposide—germ cell cancer	0.000235	0.00113	CcSEcCtD
Niacin—Headache—Etoposide—germ cell cancer	0.000233	0.00113	CcSEcCtD
Niacin—Arthralgia—Methotrexate—germ cell cancer	0.000233	0.00112	CcSEcCtD
Niacin—Myalgia—Methotrexate—germ cell cancer	0.000233	0.00112	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KITLG—germ cell cancer	0.000232	0.00177	CbGpPWpGaD
Niacin—CYP2D6—brain—germ cell cancer	0.000231	0.00124	CbGeAlD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000231	0.00112	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—AVP—germ cell cancer	0.000227	0.00173	CbGpPWpGaD
Niacin—Anaphylactic shock—Methotrexate—germ cell cancer	0.000223	0.00108	CcSEcCtD
Niacin—Nausea—Etoposide—germ cell cancer	0.000221	0.00107	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—KITLG—germ cell cancer	0.00022	0.00168	CbGpPWpGaD
Niacin—Skin disorder—Methotrexate—germ cell cancer	0.000217	0.00105	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—germ cell cancer	0.000216	0.00104	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—AVP—germ cell cancer	0.000215	0.00164	CbGpPWpGaD
Niacin—Anorexia—Methotrexate—germ cell cancer	0.000213	0.00103	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—HRAS—germ cell cancer	0.000209	0.00159	CbGpPWpGaD
Niacin—Hypotension—Methotrexate—germ cell cancer	0.000209	0.00101	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000203	0.000981	CcSEcCtD
Niacin—Insomnia—Methotrexate—germ cell cancer	0.000202	0.000974	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—germ cell cancer	0.0002	0.000967	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—germ cell cancer	0.000199	0.00096	CcSEcCtD
Niacin—Somnolence—Methotrexate—germ cell cancer	0.000198	0.000958	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—germ cell cancer	0.000196	0.000948	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—germ cell cancer	0.000194	0.000936	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000193	0.00093	CcSEcCtD
Niacin—Pain—Methotrexate—germ cell cancer	0.000191	0.000921	CcSEcCtD
Niacin—SLCO2B1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000183	0.0014	CbGpPWpGaD
Niacin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000183	0.000881	CcSEcCtD
Niacin—Urticaria—Methotrexate—germ cell cancer	0.000177	0.000856	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—germ cell cancer	0.000176	0.000851	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—germ cell cancer	0.000176	0.000851	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—FGFR3—germ cell cancer	0.000173	0.00132	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A3—germ cell cancer	0.000165	0.00126	CbGpPWpGaD
Niacin—Hypersensitivity—Methotrexate—germ cell cancer	0.000164	0.000794	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—FGFR3—germ cell cancer	0.000164	0.00125	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC22A3—germ cell cancer	0.000163	0.00124	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000163	0.00124	CbGpPWpGaD
Niacin—Asthenia—Methotrexate—germ cell cancer	0.00016	0.000773	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—KIT—germ cell cancer	0.000158	0.00121	CbGpPWpGaD
Niacin—Pruritus—Methotrexate—germ cell cancer	0.000158	0.000762	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—germ cell cancer	0.000153	0.000737	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—KIT—germ cell cancer	0.00015	0.00115	CbGpPWpGaD
Niacin—Dizziness—Methotrexate—germ cell cancer	0.000148	0.000712	CcSEcCtD
Niacin—QPRT—Disease—MYC—germ cell cancer	0.000142	0.00109	CbGpPWpGaD
Niacin—Vomiting—Methotrexate—germ cell cancer	0.000142	0.000685	CcSEcCtD
Niacin—Rash—Methotrexate—germ cell cancer	0.000141	0.000679	CcSEcCtD
Niacin—Dermatitis—Methotrexate—germ cell cancer	0.000141	0.000679	CcSEcCtD
Niacin—Headache—Methotrexate—germ cell cancer	0.00014	0.000675	CcSEcCtD
Niacin—SLC22A5—Transmembrane transport of small molecules—AVP—germ cell cancer	0.00014	0.00107	CbGpPWpGaD
Niacin—Nausea—Methotrexate—germ cell cancer	0.000133	0.00064	CcSEcCtD
Niacin—SLC16A1—Metabolism—CRABP1—germ cell cancer	0.000133	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—germ cell cancer	0.000116	0.000884	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—germ cell cancer	0.000112	0.000854	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—germ cell cancer	0.00011	0.000838	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—germ cell cancer	0.00011	0.000837	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—germ cell cancer	0.000105	0.000801	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—germ cell cancer	8.72e-05	0.000665	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—germ cell cancer	8.26e-05	0.000631	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—germ cell cancer	7.16e-05	0.000546	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—germ cell cancer	6.85e-05	0.000522	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—germ cell cancer	6.79e-05	0.000518	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—germ cell cancer	6.49e-05	0.000495	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—germ cell cancer	5.92e-05	0.000452	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—germ cell cancer	5.66e-05	0.000432	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A3—germ cell cancer	4.6e-05	0.000351	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC22A3—germ cell cancer	4.53e-05	0.000346	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CRABP1—germ cell cancer	3.69e-05	0.000282	CbGpPWpGaD
